Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 4, 2015, Pages 439-446

  Jeong, Rubi ^a   Lee, Yoon Seon ^a   Sohn, Changhwan ^a   Jeon, Jin ^a   Ahn, Shin ^a   Lim, Kyoung Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Drug induced liver injury; liver transplantation; MELD score; mortality; Prognosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BILIRUBIN; HEMOGLOBIN; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; PARACETAMOL; PRESCRIPTION DRUG; TUBERCULOSTATIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HERBAL MEDICINE; HUMAN; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; TOXIC HEPATITIS; ADOLESCENT; ADVERSE EFFECTS; BLOOD; DECISION SUPPORT SYSTEM; DRINKING BEHAVIOR; DRUG-INDUCED LIVER INJURY; END STAGE LIVER DISEASE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME; TRADITIONAL MEDICINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BILIRUBIN; DECISION SUPPORT TECHNIQUES; DRUG-INDUCED LIVER INJURY; END STAGE LIVER DISEASE; FEMALE; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; MALE; MEDICINE, TRADITIONAL; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84924015335     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.958094     Document Type: Article

References (30)

1. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
2. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996; 16:343-8.
3. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007;13:822-8.
4. Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 2012; 107:1380-7.
5. Wai CT. Presentation of drug-induced liver injury in Singapore. Singapore Med J 2006;47:116-20.
6. Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129:512-21.
7. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135: 1924- 34; 34 e1-4.
8. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002;22: 195-206.
9. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71.
10. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002;35:1282-4.
11. Kremers WK, van IM, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004;39:764-9.
12. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.
13. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-6.
14. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41:353-8.
15. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006;354:731-9.
16. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000;4:73-96; vi.
17. Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with druginduced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol 2010;105: 2396-404.
18. Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144:1419-25.
19. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-5.
20. Brandsaeter B, Broome U, Isoniemi H, Friman S, Hansen B, Schrumpf E, et al. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl 2003;9:961-9.
21. Kamath PS, Kim WR, Advanced Liver Disease Study G. The model for end-stage liver disease (MELD). Hepatology 2007; 45:797-805.
22. Devarbhavi H, Singh R, Patil M, Sheth K, Adarsh CK, Balaraju G. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis druginduced liver injury. J Gastroenterol Hepatol 2013;28:161-7.
23. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007;45:789-96.
24. Parker R, Armstrong MJ, Bruns T, Hodson J, Rowe IA, Corbett CD, et al. Reticulocyte count and hemoglobin concentration predict survival in candidates for liver transplantation. Transplantation 2014;97:463-9.
25. Zheng MH, Shi KQ, Lin XF, Xiao DD, Chen LL, Liu WY, et al. A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network. J Viral Hepat 2013;20:248-55.
26. Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005;42: 481-9.
27. Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Caliz I, Gonzalez-Jimenez A, et al. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology 2014;147:109-18.
28. Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006;43:618-31.
29. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Cobaugh DJ, Youniss J, Omslaer JC, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.AmJEmergMed2002;20:391-452.
30. Seeff LB. Herbal hepatotoxicity. Clin Liver Dis 2007;11: 577-96.